Sechenov University, Center for Clinical Research on Medications, Russia has completed clinical trials of a COVID-19 vaccine candidate while proved that the vaccine is safe as the volunteers will be discharged on 15 July and 20 July.
According to Russian news agency on Monday, the Chief Researcher and Head of the Center, Elena Smolyarchuk said study data showed the vaccine candidate’s effectiveness as the trial participants will be monitored on an outpatient basis after being discharged.
An intramuscular solution of the vaccine was tested at the Burdenko Military Hospital while Sechenov University assessed the vaccine in the form a powder for the preparation of an intramuscular solution. The first stage of testing at the university commenced on 18 June, 2020 with in a group of 18 participants. The second group of the study involved 20 volunteers who were vaccinated on 23 June, 2020.
Prior to the human trials, the vaccine was tested for its toxicity, safety, immunogenicity and effectiveness in large and small animals at the Russian Defence Ministry’s 48th Central research institute. Last month, Russia granted authorisation for clinical trials of two formulations of the Covid-19 vaccine candidate, which was developed by the Gamaleya National Research Center for Epidemiology and Microbiology.